Here’s What Hit Baxter (BAX) in Q4

4 weeks ago 14

Soumya Eswaran

Tue, February 3, 2026 astatine 6:49 AM CST 2 min read

Pzena Investment Management recently released its fourth-quarter 2025 commentary for “Pzena Focused Value Strategy.” A transcript of the missive tin beryllium downloaded here. The 4th fourth was defined by beardown AI momentum and continued marketplace dominance by mega-cap stocks. In this environment, Pzena Focused Value Strategy underperformed the Russell 1000® Value Index, delivering a nett instrumentality of 2.5% vs. 3.8% for the Index. Given the constricted enactment successful the market, the steadfast inactive observes appealing valuation differences and believes the existent situation is favorable for semipermanent worth investors. In addition, you tin cheque the Fund's apical 5 holdings to spot its champion picks for 2025.

In its fourth-quarter 2025 capitalist letter, Pzena Focused Value Strategy highlighted Baxter International Inc. (NYSE:BAX) arsenic 1 of its starring show detractors. Baxter International Inc. (NYSE:BAX) is simply a healthcare institution that offers a portfolio of healthcare products. The one-month instrumentality for Baxter International Inc. (NYSE:BAX) was -3.31%, and its shares mislaid 36.76% implicit the past 52 weeks. On February 2, 2026, Baxter International Inc. (NYSE:BAX) banal closed astatine $19.87 per share, with a marketplace capitalization of $10.214 billion

Pzena Focused Value Strategy stated the pursuing regarding Baxter International Inc. (NYSE:BAX) successful its 4th fourth 2025 capitalist letter:

"Basic materials, wellness care, and exertion were the largest detracting sectors during the quarter. Global aesculapian products institution Baxter International Inc. (NYSE:BAX) was anemic pursuing disappointing 3rd 4th results and a dividend cut. Delayed normalization of IV fluid volumes pursuing Hurricane Helene continued to unit revenue, portion the voluntary Novum pump ship-hold announced past 4th is present expected to widen into 2026, adding further near-term pressure."

Is Baxter International Inc. (BAX) the Most Undervalued Healthcare Stock to Buy According to Analysts?

Baxter International Inc. (NYSE:BAX) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 38 hedge money portfolios held Baxter International Inc. (NYSE:BAX) astatine the extremity of the 3rd quarter, up from 31 successful the erstwhile quarter. While we admit the imaginable of Baxter International Inc. (NYSE:BAX) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered Baxter International Inc. (NYSE:BAX) and shared Artisan Mid Cap Value Fund's views connected the institution successful the erstwhile quarter. In addition, delight cheque retired our hedge money capitalist letters Q4 2025 page for much capitalist letters from hedge funds and different starring investors.